Literature DB >> 26837921

Giant Cell Tumor of Bone.

David R Lucas1.   

Abstract

This article provides an overview of giant cell tumor, including the typical clinical, radiographic, and pathologic findings, as well as some unusual features, such as multifocality and metastases. The article addresses recent advances in the molecular biology of giant cell tumor, particularly receptor activator of nuclear factor kappa B (RANK)-ligand signaling, in addition to novel anti-RANK-ligand therapy, the use of which seems promising for unresectable and metastatic tumors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID: 26837921     DOI: 10.1016/j.path.2011.07.012

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  3 in total

1.  CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study.

Authors:  Mousa A Al-Abbadi; Mohammed J Al-Yousef; Mohammad M Yousef; Salwa S Sheikh; Nidal M Almasri; Samir S Amr
Journal:  Avicenna J Med       Date:  2016 Jul-Sep

2.  A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences.

Authors:  Alessandro De Vita; Silvia Vanni; Giacomo Miserocchi; Valentina Fausti; Federica Pieri; Chiara Spadazzi; Claudia Cocchi; Chiara Liverani; Chiara Calabrese; Roberto Casadei; Federica Recine; Lorena Gurrieri; Alberto Bongiovanni; Toni Ibrahim; Laura Mercatali
Journal:  Biomedicines       Date:  2022-02-03

Review 3.  State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics.

Authors:  Anna Parmeggiani; Marco Miceli; Costantino Errani; Giancarlo Facchini
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.